asx emv
- Home
- asx emv
Public
Opening a new frontier in treating Parkinson’s disease
- Review
- November 11, 2022
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
EMVision takes key step in advancing stroke diagnosis technology
Medical device company EMVision (ASX: EMV) has reported “excellent” results from a study gauging the effectiveness of its cutting-edge neurodiagnostic technology for the identification of stroke and stroke types. The multi-site study – known as EMView – involved the testing of diagnostic algorithms on unseen data from 307 participants across the Liverpool, Royal Melbourne, and
Read MorePublic
EMVision analysis confirms hyperacute and acute ischaemia stroke detection capabilities
Ischaemia is a condition in which the blood supply to any part of the body is so severely restricted that it receives no oxygen and can result in a stroke. Early detection is crucial, and so, medical devices company EMVision (ASX: EMV) has been conducting multi-site clinical trials to advance its neurodiagnostic AI algorithms to
Read MorePublic
EMVision names brain scanner device emu to signal future-first approach
The Australian bird Emu is known for many things—for instance, it’s not a commitment kind of bird, with its relationships typically lasting for only about five months. Even so, Emus set a great example for couples in post-pregnancy, as the male and female Emus share the load after an egg is hatched, with the male
Read MorePublic
